Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?

Expert Opin Pharmacother. 2016;17(4):457-61. doi: 10.1517/14656566.2016.1146686. Epub 2016 Feb 15.

Francesco Panza^{1

2

3}, Davide Seripa³, Vincenzo Solfrizzi⁴, Bruno P Imbimbo⁵, Andrea Santamato⁶, Madia Lozupone¹, Rosa Capozzo^{1

2}, Camilla Prete⁷, Alberto Pilotto⁷, Antonio Greco³, Giancarlo Logroscino^{1

2}

¹ a Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs , University of Bari Aldo Moro , Bari , Italy.
² b Department of Clinical Research in Neurology , University of Bari Aldo Moro, 'Pia Fondazione Cardinale G. Panico' , Lecce , Italy.
³ c Geriatric Unit & Laboratory of Gerontology and Geriatrics, Department of Medical Sciences , IRCCS 'Casa Sollievo della Sofferenza' , Foggia , Italy.
⁴ d Geriatric Medicine-Memory Unit and Rare Disease Centre , University of Bari Aldo Moro , Bari , Italy.
⁵ e Research & Development Department , Chiesi Farmaceutici , Parma , Italy.
⁶ f Physical Medicine and Rehabilitation Section, 'OORR' Hospital , University of Foggia , Foggia , Italy.
⁷ g Department of OrthoGeriatrics, Rehabilitation and Stabilization, Frailty Area , E.O. Galliera NR-HS Hospital , Genova , Italy.

No abstract available

Publication types